Assess and improve organisational readiness for regulatory inspection, covering documentation, personnel preparation, logistics, and response planning.
Expected: A risk-rated analysis of inspection focus areas specific to the inspecting authority. On failure: If recent 483/warning letter data is unavailable, consult the FDA warning letter database, EMA inspection reports, or industry publications for the most current trends.
Expected: A quantified readiness assessment with prioritised remediation actions. On failure: If overall readiness is below 70%, consider requesting an inspection delay (if permitted) and implementing emergency remediation.
Prepare an organisation for regulatory inspection by assessing readiness against agency-specific focus areas (FDA, EMA, MHRA). Covers warning letter and 483 theme analysis, mock inspection protocols, document bundle preparation, inspection logistics, and response template creation. Use when a regulatory inspection has been announced or is anticipated, when a periodic self-assessment is due, when new systems have been implemented since the last inspection, or after a significant audit finding that may attract regulatory attention. Source: pjt222/development-guides.